Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Betteridge

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Rheumatology. Supplement|August 21, 2003
Bone and joint diseases around the world. Arthritis--the greatest health, disability, and civil rights challenge: a UK and international perspectiveNeil Betteridge
Annals of the Rheumatic Diseases|May 8, 2010
Self-management of rheumatic diseases: state of the art and future perspectivesMaura D Iversen, Alison Hammond, Neil Betteridge
Current Medical Research and Opinion|April 8, 2018
Non-invasive patient-controlled analgesia in the management of acute postoperative pain in the hospital settingBart Morlion, Michael Schäfer, Neil Betteridge, et al.
Best Practice & Research. Clinical Rheumatology|August 18, 2020
What do people need?Neil Betteridge, Connie Camilleri, Linda Stoyanoff, et al.
Annals of the Rheumatic Diseases|March 12, 2018
Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR)Désirée van der Heijde, David I Daikh, Neil Betteridge, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 14, 2018
Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR)Désirée van der Heijde, David I Daikh, Neil Betteridge, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 5, 2025
Beyond Cost: Observations on Clinical and Patient Benefits of Biosimilars in Real-World SettingsTore K Kvien, Neil Betteridge, Ines Brückmann, et al.
BJGP Open|February 20, 2020
Understanding the patient voice in gout: a quantitative study conducted in EuropeMarc De Meulemeester, Elsa Mateus, Hilda Wieberneit-Tolman, et al.
Journal of Global Health|April 16, 2026
Hidden in plain sight: the fourth UN High-Level Meeting on the Prevention and Control of Noncommunicable Diseases and the Promotion of Mental Health and Well-being missed the mark on chronic pain and mobility impairmentAndrew M Briggs, Neil Betteridge, Fiona M Blyth, et al.
Rheumatic Diseases Clinics of North America|May 7, 2026
Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases GloballyAnthony D Woolf, Kristina E Åkesson, Neil Betteridge, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Rheumatology. Supplement|August 21, 2003
Bone and joint diseases around the world. Arthritis--the greatest health, disability, and civil rights challenge: a UK and international perspectiveNeil Betteridge
Annals of the Rheumatic Diseases|May 8, 2010
Self-management of rheumatic diseases: state of the art and future perspectivesMaura D Iversen, Alison Hammond, Neil Betteridge
Current Medical Research and Opinion|April 8, 2018
Non-invasive patient-controlled analgesia in the management of acute postoperative pain in the hospital settingBart Morlion, Michael Schäfer, Neil Betteridge, et al.
Best Practice & Research. Clinical Rheumatology|August 18, 2020
What do people need?Neil Betteridge, Connie Camilleri, Linda Stoyanoff, et al.
Annals of the Rheumatic Diseases|March 12, 2018
Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR)Désirée van der Heijde, David I Daikh, Neil Betteridge, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 14, 2018
Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR)Désirée van der Heijde, David I Daikh, Neil Betteridge, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 5, 2025
Beyond Cost: Observations on Clinical and Patient Benefits of Biosimilars in Real-World SettingsTore K Kvien, Neil Betteridge, Ines Brückmann, et al.
BJGP Open|February 20, 2020
Understanding the patient voice in gout: a quantitative study conducted in EuropeMarc De Meulemeester, Elsa Mateus, Hilda Wieberneit-Tolman, et al.
Journal of Global Health|April 16, 2026
Hidden in plain sight: the fourth UN High-Level Meeting on the Prevention and Control of Noncommunicable Diseases and the Promotion of Mental Health and Well-being missed the mark on chronic pain and mobility impairmentAndrew M Briggs, Neil Betteridge, Fiona M Blyth, et al.
Rheumatic Diseases Clinics of North America|May 7, 2026
Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases GloballyAnthony D Woolf, Kristina E Åkesson, Neil Betteridge, et al.
Pageof 3